Metropolitan Life Insurance Company (MetLife)’s Brady Corp BRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,413
| Closed | -$130K | – | 2467 |
|
|
2023
Q1 | $130K | Sell |
2,413
-464
| -16% | -$24.3K | 0.01% | 872 |
|
|
2022
Q4 | $136K | Hold |
2,877
| – | – | 0.01% | 901 |
|
|
2022
Q3 | $120K | Hold |
2,877
| – | – | 0.01% | 914 |
|
|
2022
Q2 | $136K | Hold |
2,877
| – | – | 0.01% | 894 |
|
|
2022
Q1 | $133K | Sell |
2,877
-9,640
| -77% | -$471K | ﹤0.01% | 1025 |
|
|
2021
Q4 | $675K | Hold |
12,517
| – | – | 0.01% | 1227 |
|
|
2021
Q3 | $635K | Sell |
12,517
-1,161
| -8% | -$61.2K | 0.01% | 1290 |
|
|
2021
Q2 | $767K | Buy |
13,678
+852
| +7% | +$47.9K | 0.01% | 1213 |
|
|
2021
Q1 | $686K | Sell |
12,826
-630
| -5% | -$32.9K | 0.01% | 1210 |
|
|
2020
Q4 | $711K | Hold |
13,456
| – | – | 0.01% | 1125 |
|
|
2020
Q3 | $539K | Sell |
13,456
-1,390
| -9% | -$63.7K | 0.01% | 1165 |
|
|
2020
Q2 | $695K | Buy |
14,846
+591
| +4% | +$27.2K | 0.01% | 979 |
|
|
2020
Q1 | $643K | Sell |
14,255
-872
| -6% | -$44.4K | 0.01% | 917 |
|
|
2019
Q4 | $866K | Sell |
15,127
-267
| -2% | -$15K | 0.01% | 979 |
|
|
2019
Q3 | $817K | Hold |
15,394
| – | – | 0.01% | 976 |
|
|
2019
Q2 | $759K | Buy |
15,394
+217
| +1% | +$10.4K | 0.01% | 1056 |
|
|
2019
Q1 | $704K | Sell |
15,177
-329
| -2% | -$15.1K | 0.01% | 1094 |
|
|
2018
Q4 | $674K | Hold |
15,506
| – | – | 0.01% | 1025 |
|
|
2018
Q3 | $678K | Hold |
15,506
| – | – | 0.01% | 1163 |
|
|
2018
Q2 | $598K | Buy |
15,506
+421
| +3% | +$16.2K | 0.01% | 1193 |
|
|
2018
Q1 | $560K | Buy |
15,085
+3
| +0% | +$114 | 0.01% | 1200 |
|
|
2017
Q4 | $572K | Sell |
15,082
-16,490
| -52% | -$635K | 0.01% | 1197 |
|
|
2017
Q3 | $1.2M | Hold |
31,572
| – | – | 0.01% | 1148 |
|
|
2017
Q2 | $1.07M | Sell |
31,572
-1,009
| -3% | -$37.5K | 0.01% | 1208 |
|
|
2017
Q1 | $1.26M | Hold |
32,581
| – | – | 0.01% | 1126 |
|
|
2016
Q4 | $1.22M | Sell |
32,581
-808
| -2% | -$29.1K | 0.01% | 1196 |
|
|
2016
Q3 | $1.16M | Hold |
33,389
| – | – | 0.01% | 1202 |
|
|
2016
Q2 | $1.02M | Hold |
33,389
| – | – | 0.01% | 1244 |
|
|
2016
Q1 | $896K | Sell |
33,389
-992
| -3% | -$23.9K | 0.01% | 1228 |
|
|
2015
Q4 | $790K | Hold |
34,381
| – | – | 0.01% | 1311 |
|
|
2015
Q3 | $676K | Hold |
34,381
| – | – | ﹤0.01% | 1427 |
|
|
2015
Q2 | $851K | Sell |
34,381
-1,536
| -4% | -$40.3K | 0.01% | 1400 |
|
|
2015
Q1 | $1.02M | Hold |
35,917
| – | – | 0.01% | 1183 |
|
|
2014
Q4 | $982K | Hold |
35,917
| – | – | 0.01% | 1326 |
|
|
2014
Q3 | $806K | Hold |
35,917
| – | – | 0.01% | 1408 |
|
|
2014
Q2 | $1.07M | Hold |
35,917
| – | – | 0.01% | 1302 |
|
|
2014
Q1 | $975K | Hold |
35,917
| – | – | 0.01% | 1371 |
|
|
2013
Q4 | $1.11M | Hold |
35,917
| – | – | 0.01% | 1260 |
|
|
2013
Q3 | $1.09M | Hold |
35,917
| – | – | 0.01% | 1230 |
|
|
2013
Q2 | $1.1M | Buy |
+35,917
| New | +$1.17M | 0.01% | 1172 |
|
Other funds holding BRC
VBA
Metropolitan Life Insurance Company (MetLife)'s BRC Position: Q2 2023 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Brady Corp (BRC) in Q2 2023, closing a stake of 2,413 shares — an estimated $130K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in BRC in Q2 2013 and held it in 40 quarters. The position peaked at $1.26M in Q1 2017. 221 funds tracked by Wall St. Rank hold BRC as of Q2 2023.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Brady Corp position as of Q2 2023 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,413 Brady Corp shares in Q2 2023, an estimated $130K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Brady Corp in Q2 2013 and held it in 40 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Brady Corp position peaked at $1.26M in Q1 2017.
- 221 funds tracked by Wall St. Rank held Brady Corp as of Q2 2023.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.